Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 985015711 | 9850157 | 11 | F | 20160727 | 20140128 | 20160801 | EXP | US-PFIZER INC-2014022812 | PFIZER | 53.00 | YR | M | Y | 0.00000 | 20160801 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 985015711 | 9850157 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | UNK | N | 20702 | FILM-COATED TABLET | ||||||||
| 985015711 | 9850157 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10 MG, 1X/DAY | N | 20702 | 10 | MG | FILM-COATED TABLET | QD | |||||
| 985015711 | 9850157 | 3 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, 1X/DAY | N | 20702 | 20 | MG | FILM-COATED TABLET | QD | |||||
| 985015711 | 9850157 | 4 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, 1X/DAY | N | 20702 | 20 | MG | FILM-COATED TABLET | QD | |||||
| 985015711 | 9850157 | 5 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, 1X/DAY (EVERY NIGHT AT BEDTIME) | N | 20702 | 40 | MG | FILM-COATED TABLET | QD | |||||
| 985015711 | 9850157 | 6 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, 1X/DAY | N | 20702 | 40 | MG | FILM-COATED TABLET | QD | |||||
| 985015711 | 9850157 | 7 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Oral | UNK | N | 20702 | FILM-COATED TABLET | ||||||||
| 985015711 | 9850157 | 8 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Oral | 40 MG, DAILY (EVERY DAY) | N | 20702 | 40 | MG | FILM-COATED TABLET | ||||||
| 985015711 | 9850157 | 9 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 1 DF, DAILY | 0 | 1 | DF | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 985015711 | 9850157 | 1 | Low density lipoprotein increased |
| 985015711 | 9850157 | 2 | Cardiovascular event prophylaxis |
| 985015711 | 9850157 | 3 | Blood cholesterol increased |
| 985015711 | 9850157 | 9 | Gastrooesophageal reflux disease |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 985015711 | 9850157 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 985015711 | 9850157 | Fatigue | |
| 985015711 | 9850157 | Myalgia | |
| 985015711 | 9850157 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 985015711 | 9850157 | 1 | 1999 | 0 | ||
| 985015711 | 9850157 | 2 | 19990616 | 0 | ||
| 985015711 | 9850157 | 3 | 20010618 | 0 | ||
| 985015711 | 9850157 | 4 | 20100504 | 0 | ||
| 985015711 | 9850157 | 5 | 20110104 | 0 | ||
| 985015711 | 9850157 | 6 | 20130823 | 0 | ||
| 985015711 | 9850157 | 8 | 20121221 | 0 |